7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?

7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?

<h4>Background</h4>The UK introduced the 7-valent pneumococcal conjugate vaccine (PCV7) into the national vaccination program in September 2006. Previous modelling assumed that the likely impact of PCV7 on invasive pneumococcal disease (IPD) would be similar to the US experience with PCV...

Full description

Bibliographic Details
Main Authors: Yoon Hong Choi, Mark Jit, Nigel Gay, Nick Andrews, Pauline A Waight, Alessia Melegaro, Robert George, Elizabeth Miller
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22022559/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22022559/?tool=EBI

Similar Items